Markets:

Overview

News

Currencies

International

Treasuries

Apellis Pharmaceuticals, Inc. - Common Stock (NQ:APLS)

19.73 -0.37 (-1.84%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Apellis Pharmaceuticals, Inc. - Common Stock

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

10 Health Care Stocks With Whale Alerts In Today's Session ↗

April 19, 2023

Via Benzinga

Wedbush Maintains Neutral Rating for Apellis Pharmaceuticals: Here's What You Need To Know ↗

April 17, 2023

Via Benzinga

Apellis Partners with Acclaimed Actor Henry Winkler to Raise Awareness of Geographic Atrophy (GA) for the GA Won’t Wait™ Campaign

April 17, 2023

From Apellis Pharmaceuticals, Inc.

Via GlobeNewswire

9 Analysts Have This to Say About Apellis Pharmaceuticals ↗

April 14, 2023

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

April 12, 2023

Via Benzinga

Why Apellis Pharmaceuticals Stock Is Soaring Today ↗

April 03, 2023

Rare disease-focused Apellis Pharmaceuticals Inc (NASDAQ: APLS) is reportedly drawing takeover interest from large drugmakers.

Via Benzinga

2 Best Growth Stocks to Buy in April ↗

April 03, 2023

Takeover interest is spurring these two biotech stocks higher.

Via The Motley Fool

Apellis Pharmaceuticals's Return On Capital Employed Insights ↗

February 22, 2023

Via Benzinga

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 06, 2023

From Apellis Pharmaceuticals, Inc.

Via GlobeNewswire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

April 03, 2023

Via Benzinga

Apellis Pharmaceuticals Inc. (NASDAQ: APLS) Making Surprising Moves in Monday Session

April 03, 2023

Via Investor Brand Network

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 03, 2023

Via Benzinga

Why Are Apellis Pharmaceuticals Shares Trading Higher Today? ↗

February 21, 2023

Via Benzinga

Apellis Pharmaceuticals, VirTra And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗

April 03, 2023

U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 06, 2023

From Apellis Pharmaceuticals, Inc.

Via GlobeNewswire

Apellis Pharmaceuticals to Present at Upcoming Investor Conferences

March 01, 2023

From Apellis Pharmaceuticals, Inc.

Via GlobeNewswire

Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Option to Purchase Additional Shares

February 27, 2023

From Apellis Pharmaceuticals, Inc.

Via GlobeNewswire

Wall Street Upgraded This Stock's Price Target After a New Approval: Is It a Buy? ↗

February 27, 2023

The company's lead therapy was just approved for another indication.

Via The Motley Fool

Why Apellis Pharmaceuticals Stock Surged This Week ↗

February 24, 2023

A highly eventful five days for the company saw bulls pile into its shares.

Via The Motley Fool

Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

February 22, 2023

From Apellis Pharmaceuticals, Inc.

Via GlobeNewswire

Apellis Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

February 22, 2023

From Apellis Pharmaceuticals, Inc.

Via GlobeNewswire

Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results

February 21, 2023

From Apellis Pharmaceuticals, Inc.

Via GlobeNewswire

Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 21, 2023

Gainers Arbe Robotics Ltd. (NASDAQ: ARBE) gained 62.8% to $7.08. Arbe Robotics is expected to report its financial results for the fourth quarter on Thursday, March 2, 2023.

Via Benzinga

Apellis Surges To Four-Month High — Sending Rival Iveric Tumbling — On A First-Ever Approval ↗

February 21, 2023

Apellis is soon to launch its newest drug, Syfovre, for geographic atrophy patients.

Via Investor's Business Daily

Manitowoc, Helix Energy Solutions, JELD-WEN Holding And Other Big Stocks Moving Higher On Tuesday ↗

February 21, 2023

U.S. stocks traded lower, with the Dow Jones dropping around 450 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 21, 2023

Via Benzinga

Why Owlet Shares Are Trading Higher By Over 45%; Here Are 20 Stocks Moving Premarket ↗

February 21, 2023

Gainers Troika Media Group Inc (NASDAQ: TRKA) shares rose 65.9% to $0.37 in pre-market trading after dropping 4% on Friday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

February 21, 2023

It's time to start another day of trading with a breakdown of the biggest pre-market stock movers traders need to know about for Tuesday!

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 20, 2023

Via Benzinga

FDA Approves SYFOVRE™ (pegcetacoplan injection) as the First and Only Treatment for Geographic Atrophy (GA), a Leading Cause of Blindness

February 17, 2023

From Apellis Pharmaceuticals, Inc.

Via GlobeNewswire

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Apellis Pharmaceuticals, Inc. - Common Stock (NQ:APLS)

All News about Apellis Pharmaceuticals, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today